Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy

Pegylated-interferon-α based therapy for the treatment of chronic hepatitis C (CHC) is considered suboptimal as not all patients respond to the treatment and it is associated with several side effects that could lead to dose reduction and/or termination of therapy. The currently used markers to moni...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Mediators Inflamm
Main Authors: Refaat, Bassem, Ashshi, Ahmed Mohamed, El-Shemi, Adel Galal, Azhar, Esam
פורמט: Artigo
שפה:Inglês
יצא לאור: Hindawi Publishing Corporation 2015
נושאים:
Review Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4417604/
https://ncbi.nlm.nih.gov/pubmed/25969625
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/287640
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים